Prelude Therapeutics Inc. (PRLD)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
26 May 2023 |
VADDI KRISHNA |
CEO |
25 May 2023 |
900 |
5.31 |
4,779 |
26 May 2023 |
VADDI KRISHNA |
CEO |
24 May 2023 |
1,000 |
5.01 |
5,011 |
25 May 2023 |
LIM BRYANT DAVID |
Chief Legal Officer, Corp Sec. |
24 May 2023 |
2,400 |
5.39 |
12,936 |
25 May 2023 |
CHARDONNET LAURENT |
Chief Financial Officer |
23 May 2023 |
5,000 |
5.50 |
27,500 |
25 May 2023 |
VADDI KRISHNA |
CEO |
23 May 2023 |
11,856 |
5.63 |
66,749 |
24 May 2023 |
ORBIMED ADVISORS LLC |
Director , 10% |
22 May 2023 |
869,565 |
5.75 |
4,999,999 |
21 Dec 2022 |
VADDI KRISHNA |
CEO |
20 Dec 2022 |
19,188 |
5.13 |
98,446 |
12 Dec 2022 |
CHARDONNET LAURENT |
Chief Financial Officer |
08 Dec 2022 |
10,000 |
4.76 |
47,600 |
01 Jun 2022 |
CHARDONNET LAURENT |
Chief Financial Officer |
01 Jun 2022 |
10,000 |
4.23 |
42,300 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock